These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10886501)

  • 21. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
    Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibilities of demonstration of growth factors in chronic wounds. Demonstration of RNA and protein in wound tissue].
    Wagner S; Kimmerle E; Coerper S; Becker HD
    Zentralbl Chir; 2000; 125 Suppl 1():60-2. PubMed ID: 10929649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs.
    Klekamp JG; Jarzecka K; Perkett EA
    Am J Pathol; 1999 Mar; 154(3):823-31. PubMed ID: 10079260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
    Winther H; Ahmed A; Dantzer V
    Placenta; 1999 Jan; 20(1):35-43. PubMed ID: 9950143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor (VEGF) and its corresponding receptors (flt-1 and flk-1) in the bovine oviduct.
    Gabler C; Einspanier A; Schams D; Einspanier R
    Mol Reprod Dev; 1999 Aug; 53(4):376-83. PubMed ID: 10398412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells.
    Ankoma-Sey V; Wang Y; Dai Z
    Hepatology; 2000 Jan; 31(1):141-8. PubMed ID: 10613739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.
    Detmar M; Brown LF; Claffey KP; Yeo KT; Kocher O; Jackman RW; Berse B; Dvorak HF
    J Exp Med; 1994 Sep; 180(3):1141-6. PubMed ID: 8064230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI
    Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.
    Hovey RC; Goldhar AS; Baffi J; Vonderhaar BK
    Mol Endocrinol; 2001 May; 15(5):819-31. PubMed ID: 11328861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
    Cunningham SA; Arrate MP; Brock TA; Waxham MN
    Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
    Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
    Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy.
    Otani N; Minami S; Yamoto M; Shikone T; Otani H; Nishiyama R; Otani T; Nakano R
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3845-51. PubMed ID: 10523040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
    Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
    J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor.
    Supp DM; Supp AP; Bell SM; Boyce ST
    J Invest Dermatol; 2000 Jan; 114(1):5-13. PubMed ID: 10620108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.